Many people think that there symptoms of bph is a physiological aging phenomenon, not a disease. According to the survey, only about 1 / 3 of patients will do the treatment of benign prostatic hyperplasia, and one received through formal channels, it is only a little. Many middle-aged men usually went hospital for treatment when it’s too late, even with acute urinary retention, missed a reasonable opportunity of treatment and then had to be treated through surgery.
A reasonable treatment of BPH refers to the progression we are talking about is in early, medium-terms with drug treatment for the source of the disease, to cure, reduce prostate volume, thereby reducing the incidence of acute urinary retention and surgical rates. BPH is recognized as a Preferred medical treatment home and abroad.
According to a pharmacological response to reductase inhibitor finasteride made for the treatment of bph clinical studies ,which showed that, with an average following 4 to5 years later, using the reductase inhibitors in the treatment and placebo, compared with finasteride, can reduce prostate volume up to 43%. Long-term use can not only reduce the prostate volume, improve urinary symptoms, increase urinary flow rate, but also reducing the incidence of acute urinary retention in 68%, and 64%, and can suffer from bph patients to avoid the need for surgical treatment of the patient themselves with the symptoms of disease awareness and enthusiasm for the correct treatment is a reasonable management and treatment of diseases, an important prerequisite. Any age over 50-year-old men belong to the occurrence of bph in high risk populations, through the following international prostate symptom score sheet, to assess their need to receive medical treatment. Continue reading ‘An Introduction to BPH Cure’ »
Incoming search terms: